The archbishop advocated for the human rights of people living with HIV and tuberculosis
Features
November 10, 2021
Strengthening research and science leadership capacity of African researchers
October 20, 2021
The call is endorsed by a global coalition advocating for a fully funded and resourced TB vaccine pipeline by 2023
October 18, 2021
IAVI and African Vaccine Manufacturing Initiative host virtual forum
September 30, 2021
Nkengasong was a founding leader of PEPFAR and has served on IAVI’s board since 2018.
Janssen-sponsored trial in sub-Saharan Africa discontinued due to lack of efficacy.
August 9, 2021
New leadership program positions homegrown scientists to drive research into HIV and other infectious diseases in Africa and India.
August 3, 2021
Vaccine candidate targets vulnerabilities common across many HIV-1 variants.
June 18, 2021
A Q&A with Dr. Gagandeep Kang, professor of microbiology at the Wellcome Trust Research Laboratory, held on May 12, 2021, and co-organized by IAVI...
A commentary by Mark Feinberg, M.D., Ph.D., IAVI president and CEO
IAVI’s Dr. Jayanta Bhattacharya, of the Translational Health Science and Technology Institute, India, is interviewed by DBT/Wellcome Trust India All...
Show More
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
